EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Bevacizumab and a Bevacizumab-Methylcellulose Mixture on Intraocular Pressure After Deep Sclerectomy: A Double-Blind, Randomized Controlled Clinical Trial

Ali Mostafaei, Nazli Taheri, Neda Moghaddam, Hanieh Salehi-Pourmehr

Journal of Research in Clinical Medicine · 13.05.2026 · 14 · 34906

DOI: 10.34172/jrcm.026.34906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Research in Clinical Medicine, online erschienen am 13.05.2026. Verfasst von Ali Mostafaei und 3 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to compare the effectiveness of bevacizumab administered alone versus combined with methylcellulose in reducing intraocular pressure during a six-month period following deep sclerectomy.

Methods

This comparative investigation, serving as an extension of a prospective randomized controlled trial, enrolled 30 eyes from 30 individuals diagnosed with open-angle glaucoma (15 eyes assigned to each treatment arm). Among participants, 33.3% presented with secondary open-angle glaucoma (pseudoexfoliation syndrome), while 66.7% had primary open-angle glaucoma requiring deep sclerectomy. Postoperatively, Group A received subconjunctival bevacizumab injections, whereas Group B received subconjunctival injections of a bevacizumab-methylcellulose mixture. Primary outcome measures included surgical success rates and bleb morphology assessment.

Results

Among eligible participants, 66.7% were male and 33.3% were female. Visual acuity measurements demonstrated no significant intergroup differences before or after surgery. Although Group B exhibited greater IOP reduction compared to Group A, statistically significant differences between groups emerged only at postoperative day one and at the six-month follow-up assessment. Success rates (complete or relative success) at six months showed no statistically significant variation between groups (*P*>0.05), nor did mean preoperative and postoperative values with standard deviations differ significantly. Vascularity scores decreased markedly in Group B at one-month, three-month, and six-month evaluations relative to Group A.

Conclusion

Utilizing a sustained-release delivery system that extends bevacizumab bioavailability appears to enhance surgical outcomes compared to conventional isolated bevacizumab ocular injections. Trial Registration: IRCT2016121831450N1

Zitieren

APA

Mostafaei, A., Taheri, N., Moghaddam, N., & Salehi-Pourmehr, H. (2026). Efficacy of Bevacizumab and a Bevacizumab-Methylcellulose Mixture on Intraocular Pressure After Deep Sclerectomy: A Double-Blind, Randomized Controlled Clinical Trial. Journal of Research in Clinical Medicine, 14, 34906. https://doi.org/10.34172/jrcm.026.34906

Vancouver

Mostafaei A, Taheri N, Moghaddam N, Salehi-Pourmehr H. Efficacy of Bevacizumab and a Bevacizumab-Methylcellulose Mixture on Intraocular Pressure After Deep Sclerectomy: A Double-Blind, Randomized Controlled Clinical Trial. Journal of Research in Clinical Medicine. 2026;14:34906. doi:10.34172/jrcm.026.34906

BibTeX
@article{Mostafaei2026,
  author = {Mostafaei, Ali and Taheri, Nazli and Moghaddam, Neda and Salehi-Pourmehr, Hanieh},
  title = {Efficacy of Bevacizumab and a Bevacizumab-Methylcellulose Mixture on Intraocular Pressure After Deep Sclerectomy: A Double-Blind, Randomized Controlled Clinical Trial},
  journal = {Journal of Research in Clinical Medicine},
  year = {2026},
  volume = {14},
  pages = {34906},
  doi = {10.34172/jrcm.026.34906}
}
Kostenlos starten →